Tumour necrosis factor levels during acute rejection and acute tubular necrosis in renal transplant recipients. 2000

M C Wiggins, and M Bracher, and A Mall, and R Hickman, and S C Robson, and D Kahn
Department of Surgery, and Medical Research Council Liver Centre, University of Cape Town, South Africa.

Plasma tumour necrosis factor levels were measured serially in 16 patients following renal transplantation, and in 10 patients on haemodialysis and in 12 patients on peritoneal dialysis. The patients on peritoneal dialysis had lower plasma TNF levels than the patients on haemodialysis. There was a decrease in TNF levels immediately following renal transplantation; this is probably related to the bolus doses of methylprednisolone administered intra-operatively. Patients with acute rejection had higher levels of TNF than non-rejecting patients. The increase in TNF levels in rejecting patients was observed 2 days before the clinical manifestation of acute rejection. There was a marked decrease in TNF levels in rejecting patients in response to treatment with steroids. Patients with delayed graft function had higher levels of TNF on the first post-operative day compared to patients with immediate function. These changes in plasma TNF levels following renal transplantation have important clinical and therapeutic implications.

UI MeSH Term Description Entries
D007683 Kidney Tubular Necrosis, Acute Acute kidney failure resulting from destruction of EPITHELIAL CELLS of the KIDNEY TUBULES. It is commonly attributed to exposure to toxic agents or renal ISCHEMIA following severe TRAUMA. Lower Nephron Nephrosis,Acute Kidney Tubular Necrosis,Lower Nephron Nephroses,Nephron Nephroses, Lower,Nephron Nephrosis, Lower,Nephroses, Lower Nephron,Nephrosis, Lower Nephron
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014181 Transplantation Immunology A general term for the complex phenomena involved in allo- and xenograft rejection by a host and graft vs host reaction. Although the reactions involved in transplantation immunology are primarily thymus-dependent phenomena of cellular immunity, humoral factors also play a part in late rejection. Immunology, Transplantation
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015592 Immunoradiometric Assay Form of radioimmunoassay in which excess specific labeled antibody is added directly to the test antigen being measured. Assay, Immunoradiometric,Assays, Immunoradiometric,Immunoradiometric Assays

Related Publications

M C Wiggins, and M Bracher, and A Mall, and R Hickman, and S C Robson, and D Kahn
September 1992, Transplantation,
M C Wiggins, and M Bracher, and A Mall, and R Hickman, and S C Robson, and D Kahn
October 1978, Seminars in roentgenology,
M C Wiggins, and M Bracher, and A Mall, and R Hickman, and S C Robson, and D Kahn
January 2000, Transplant international : official journal of the European Society for Organ Transplantation,
M C Wiggins, and M Bracher, and A Mall, and R Hickman, and S C Robson, and D Kahn
August 1994, Transplantation proceedings,
M C Wiggins, and M Bracher, and A Mall, and R Hickman, and S C Robson, and D Kahn
July 2009, Transplantation,
M C Wiggins, and M Bracher, and A Mall, and R Hickman, and S C Robson, and D Kahn
February 1993, Transplantation proceedings,
M C Wiggins, and M Bracher, and A Mall, and R Hickman, and S C Robson, and D Kahn
January 1979, International urology and nephrology,
M C Wiggins, and M Bracher, and A Mall, and R Hickman, and S C Robson, and D Kahn
August 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M C Wiggins, and M Bracher, and A Mall, and R Hickman, and S C Robson, and D Kahn
February 1993, Clinical science (London, England : 1979),
M C Wiggins, and M Bracher, and A Mall, and R Hickman, and S C Robson, and D Kahn
August 1994, Transplantation proceedings,
Copied contents to your clipboard!